Foundations of Asthma.

Slides:

Advertisements

Similar presentations

Immunology of Asthma through Biologics Private Practice & St Michael’s Hospital Lecturer, Division of Clinical Immunology & Allergy Department of Medicine,

Advertisements

MONOCLONAL ANTIBODIES

MOnoclonal antibodies and potential applications in migraine

Fig. 1. Pathological mechanisms of asthma

Moderate-to-Severe Asthma Management

Anti-IgE effect of the mAb omalizumab

Clinical Trials in IBD.

Evolution of Treatment Strategies Targeting IL-23 for Psoriasis

Ηωσινοφιλική κοκκιωμάτωση με πολυαγγειίτιδα – Νέες θεραπευτικές επιλογές Σακελλαρίου Γρηγόριος Αναπλ. Δντης Ρευματολογικού Τμήματος 424 ΓΣΝΕ.

Diagnosis, Evaluation, and Therapy for Severe Refractory Eosinophilic Asthma.

Allergy Testing in Children

Understanding Biologics

Clinical Review.

Stepping Up Asthma Control for Effective Management

Atopic Dermatitis Treatment Landscape

Adapted from Catley et al, Pharm Therap 2011

Chronic Idiopathic Urticaria

Anti-IgE treatment of eosinophil-associated gastrointestinal disorders

Addressing Disease Burden in Asthma

Asthma and Atopic Comorbidities

Advances in Severe Asthma Perspectives From San Antonio 2015

Program Introduction. Monoclonal Antibodies and Immunogenicity: Relevance to Clinical Practice?

Basics of Immunotherapy Potential Therapeutic Targets.

Translating Atopic Dermatitis

Production of chemokines and proinflammatory and antiinflammatory cytokines by human alveolar macrophages activated by IgE receptors Philippe Gosset,

Next-Gen Psoriasis Therapies:

Atopic Dermatitis. Introduction to a Clinical Course On New Developments In Atopic Dermatitis.

Ask the Experts.

Current application of exhaled nitric oxide in clinical practice

Demystifying the Science of Monoclonal Antibodies in Migraine

Evolving Treatment Landscape for PsA

Jennifer L. Ingram, PhD, Monica Kraft, MD

Emerging Frontline Treatments for Patients With Hodgkin Lymphoma

Current and Future Perspectives on Migraine Prevention Therapy

Personalized Therapy in Relapsed or Refractory CLL

Advancing the Treatment of IBD With Biologics

New Data on Emerging Treatments for Psoriasis

When Is Biologic Therapy Appropriate for HS?

The Evolving Treatment Landscape in Atopic Dermatitis

Current and Emerging Strategies for Management of Moderate-to-Severe Atopic Dermatitis.

Background. Advancing the Care of Patients With Moderate to Severe Atopic Dermatitis: A Case-Based Discussion.

Best Clinical Pearls in Hidradenitis Suppurativa:

Advancing Patient Care in RA

Advances in Severe Asthma Management

Guide to Atopic Dermatitis

Challenges in Severe Asthma

The Rising Cost of Healthcare and Potential Impact of Biosimilars

Anti–IL-5 treatments in patients with severe asthma by blood eosinophil thresholds: Indirect treatment comparison William Busse, MD, Geoffrey Chupp,

Achieving Asthma Control

Patient Questions and Expert Answers in Psoriasis:

Severe Asthma and Comorbidities

Critical Decision Points in Insomnia

Application of Biologics in IBD:

Diagnosis, Evaluation, and Therapy for Severe Refractory Eosinophilic Asthma.

Update on the Management of Atopic Dermatitis

Challenges in LA SCCHN.

Anti-interleukin 13 for asthma: stick or twist?

POINT: Will New Anti-eosinophilic Drugs Be Useful in Asthma Management

Biologics and biomarkers for asthma, urticaria, and nasal polyposis

AMD Therapy: Where Are We Now and Where Are We Going?

Pathophysiologic Targets of Allergic Asthma

Damal Kandadai Sriram, Govindaraj Gowri, Melvin George

Patient and Clinician Perspectives on Preventive Therapy for Migraine

Albert Y. Wu, MD, Sanjiv Sur, MD, J. Andrew Grant, MD

Monoclonal Antibodies in Migraine Prevention: What the Primary Care Physician Needs to Know.

Effect of omalizumab treatment on peripheral eosinophil and T-lymphocyte function in patients with allergic asthma Oliver Noga, MD, Gerald Hanf, MD,

Exploring the Role of Biologics in Reducing Oral Corticosteroid Use in Severe Asthma.

Foundations of Asthma.

Presentation transcript:

Foundations of Asthma

Asthma Overview

Blocking the IgE Allergic Cascade Omalizumab

Anti-IL-5 Therapy in Eosinophilic Asthma Mepolizumab, Reslizumab, Benralizumab

Anti-IL-4/IL-13 Therapy in Eosinophilic Asthma Dupilumab

Anti-IgE Monoclonal Antibody Omalizumab

Anti-IL-5 Biologics for Eosinophilic Asthma

Other Targeted Therapies for Eosinophilic Asthma

Biologics for Asthma: Warnings and Precautions

Efficacy of Biologics for Severe T2 Asthma

Does the Patient Need a Biologic?

Selecting the Right Biologic in Eosinophilic Asthma

How Long Should Biologic Therapy Be Used?

Concluding Remarks Biologics for Asthma

Abbreviations